Evaluation of anti-bacterial effects of novel formulations that target an essential metabolic pathway of the agent of Lyme disease.

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Janakiram Seshu

Funded by

UTSA VPR Office

Research Start Date

06/01/2014

Status

Active

Basic Research

Collaborative Project

Basic Research

Drug Discovery

Infectious Disease

Bioscience Research Panel